Kirkland, WA, United States of America

Narendra Vaish

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Narendra Vaish

Introduction

Narendra Vaish is a notable inventor based in Kirkland, WA (US). He has made significant contributions to the field of cancer treatment and RNA interference technologies. With a total of 7 patents, his work has the potential to impact therapeutic approaches for various diseases.

Latest Patents

One of his latest patents focuses on cancer treatment using siRNA to modulate the expression of the PRDM2/RIZ protein. This invention involves inhibitory RNA molecules that specifically inhibit mammalian RIZ2 expression, demonstrating therapeutic effects in cell proliferative diseases, such as cancer. Another significant patent involves siRNA structures designed for high activity and reduced off-target effects. This invention provides compounds, compositions, and methods for modulating the expression of target genes using RNA interference. The RNA interference molecules can be utilized in methods for preventing or treating diseases, showcasing the innovative nature of his work.

Career Highlights

Throughout his career, Narendra Vaish has worked with prominent companies such as Nitto Denko Corporation and Marina Biotech, Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.

Collaborations

Narendra has collaborated with notable individuals in his field, including Kenjirou Minomi and Jens Harborth. These collaborations have likely enhanced his research and development efforts.

Conclusion

Narendra Vaish's contributions to cancer treatment and RNA interference technologies highlight his innovative spirit and dedication to advancing medical science. His patents and collaborations reflect a commitment to improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…